Patents by Inventor Barbara Gatto

Barbara Gatto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA-based aptamers for human cathepsin G
    Patent number: 7838506
    Abstract: The present research is directed to the identification of non-peptidic inhibitors of cathepsin G characterised by high levels of selectivity and which can be efficaciously used in the treatment and prophylaxis of inflammatory occurrences and procoagulant conditions. The cathepsin G-inhibiting aptamers according to the invention consist of linear DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing.
    Type: Grant
    Filed: January 17, 2008
    Date of Patent: November 23, 2010
    Assignee: Gentium SpA
    Inventors: Manlio Palumbo, Barbara Gatto, Rodolfo Pescador, Roberto Porta, Laura Iris Ferro
  • DNA-BASED APTAMERS FOR HUMAN CATHEPSIN G
    Publication number: 20080176814
    Abstract: The present research is directed to the identification of non-peptidic inhibitors of cathepsin G characterised by high levels of selectivity and which can be efficaciously used in the treatment and prophylaxis of inflammatory occurrences and procoagulant conditions. The cathepsin G-inhibiting aptamers according to the invention consist of linear DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing.
    Type: Application
    Filed: January 17, 2008
    Publication date: July 24, 2008
    Applicant: GENTIUM SPA
    Inventors: Manlio PALUMBO, Barbara GATTO, Rodolfo PESCADOR, Roberto PORTA, Laura Iris FERRO
  • DNA-based aptamers for human cathepsin G
    Publication number: 20060148745
    Abstract: The present research is directed to the identification of non-peptidic inhibitors of cathepsin G characterised by high levels of selectivity and which can be efficaciously used in the treatment and prophylaxis of inflammatory occurrences and procoagulant conditions. The cathepsin G-inhibiting aptamers according to the invention consist of linear DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing.
    Type: Application
    Filed: September 27, 2005
    Publication date: July 6, 2006
    Inventors: Manlio Palumbo, Barbara Gatto, Rodolfo Pescador, Roberto Porta, Laura Ferro